Market Overview The global gastrointestinal drugs market is experiencing significant innovation through microbiome-targeted therapeutics that are addressing GI disease through manipulation of gut bacterial communities rather than direct treatment of disease pathophysiology. The global gastrointestinal drugs market is projected to exceed USD 80 billion through 2030, fueled by microbiome research...